Industry Satellite Symposia

This symposium is organised and entirely funded by Vertex Pharmaceuticals.
Due to pharmaceutical industry regulations, this symposium is for healthcare professionals (HCPs) and scientific professionals only, it is not open to patients or members of the public.
Thursday 5 June 2025 13:00–14:00 CEST Coral 2&3, Level 2, |
Expanding CFTR-based treatment for people with CF | |
---|---|---|
Objectives:
Chaired by: Panellists: |
||
13:00–13:15 |
Chair’s opening remarks: |
Prof. Jane Davies |
13:15–13:30 |
Review the recent advances in understanding |
Prof. Jane Davies |
13:30–13:45 |
Measurements of CFTR function and relationship with clinical outcomes |
Prof Isabelle Fajac and |
13:45–13:55 |
Discuss the continued progress and effort with genetic therapies |
Prof. Jane Davies |
13:55–14:00 |
Chair’s closing remarks |
Prof. Jane Davies |
Questions and comments from the audience is encouraged throughout the symposium.
Friday 6 June 2025 Coral 2&3, Level 2 Allianz MiCo |
Digging deeper into DPP1 (CatC) and its role in the shared pathophysiology of non-CF and CF bronchiectasis Boehringer Ingelheim Breakfast Session at ECFS 2025 |
|
---|---|---|
Co-chairs: James Chalmers and Marcus Mall | ||
Time (CEST) | Presentation title | Presenter |
08:00-08:03 | Welcome and introduction | James Chalmers |
08:03-08:23 | A case of shared pathophysiology: neutrophilic inflammation and the vicious vortex in non-CF and CF bronchiectasis |
James Chalmers |
08:23-08:43 | Investigating the role of DPP1 (CatC) in CF bronchiectasis | Marcus Mall |
08:43-08:45 | Final remarks and meeting close | Marcus Mall |

This symposium is organised and entirely funded by Vertex Pharmaceuticals.
Due to pharmaceutical industry regulations, this symposium is for healthcare professionals (HCPs) and scientific professionals only, it is not open to patients or members of the public.
Friday 6 June 2025 13:00–14:00 CEST Coral 2&3, Level 2, |
Unmet needs and clinical challenges in the CFTR modulator era | |
---|---|---|
Objectives:
Chaired by: Prof Francesco Blasi, IRCCS Ca’ Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy Speakers: Dr Gwyneth Davies, University College London, London, UK |
||
13:00–13:10 |
Chair’s opening remarks: |
Prof Francesco Blasi |
13:10–13:25 |
Addressing the clinical needs in pwCF who initiate early onto CFTRm |
Dr Gwyneth Davies |
13:25–13:40 |
Addressing the clinical needs in pwCF who start late on CFTRm with established disease |
Prof Andrea Gramegna |
13:40-13:50 |
Ageing with CF: The supporting role of the MDTs |
Dr Sarah Collins |
13:55–14:00 |
Chair’s closing remarks |
Prof Francesco Blasi |
Questions and comments from the audience is encouraged throughout the symposium.
The 48th European Cystic Fibrosis Conference has been assessed as compliant by EthicalMedTech.
Please view the assessment details: click here